Physician profile
Steven E Tooze
NPI 1427051226
$1,161.40
in general payments reported to CMS, 2019-2025
18 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $304 · 2021: $175 · 2022: $23.79 · 2023: $126 · 2024: $53.84 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $628.93 | 2019-2021 | |
| Boston Scientific Corporation | $67.57 | 2022-2025 | Rezum Generator |
| Smith+Nephew, INC. | $57.18 | 2023-2024 | Journey II, Synergy |
| Depuy Synthes Sales INC. | $50.95 | 2019 | |
| Ethicon US, LLC | $50.32 | 2023 | Stratafix |
| Pacira Pharmaceuticals Incorporated | $43.93 | 2024-2025 | Zilretta, Exparel |
| Heron Therapeutics, INC. | $38.92 | 2023-2025 | Zynrelef |
| Biocomposites INC | $34.17 | 2019 | |
| Baxter Healthcare | $33.41 | 2025 | Perclot |
| Bioventus LLC | $29.32 | 2019-2023 | Durolane |
| Ferring Pharmaceuticals INC. | $23.85 | 2019 | |
| Abbott Laboratories | $23.18 | 2021 | |
| Zimmer Biomet Holdings, INC. | $15.27 | 2019 | |
| Kci USA, INC. | $14.63 | 2019 | |
| Amgen INC. | $14.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $13.45 | 2024 | Mepilex, Mepilex Border Sacrum, Mepilex Border |
| Djo, LLC | $13.45 | 2019 | |
| Heraeus Medical, LLC. | $8.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Tooze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.